Evidence map›Paper›PMID 27270309›Full record

ArticleOncotarget2016

Aberrant methylation-mediated silencing of microRNAs contributes to HPV-induced anchorage independence.

Saskia M Wilting, Viktorian Miok, Annelieke Jaspers, Debby Boon, Hanne Sørgård, Malin Lando, Barbara C Snoek, Wessel N van Wieringen, Chris J L M Meijer, Heidi Lyng and 2 more

Abstract read
In one paragraph

Article in Oncotarget, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Cell death pathways and viruses: Role of microRNAs.Molecular therapy. Nucleic acids · 2021
    Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Dietary Modulation of the Epigenome.Physiological reviews · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Saskia M WiltingDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Viktorian MiokDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Annelieke JaspersDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Debby BoonDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Hanne SørgårdDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Malin LandoDepartment of Radiation Biology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Barbara C SnoekDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Wessel N van WieringenDepartment of Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.
Chris J L M MeijerDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Heidi LyngDepartment of Radiation Biology, Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Peter J F SnijdersDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.
Renske D M SteenbergenDepartment of Pathology, VU University Medical Center, Amsterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer and a subset of anogenital and head-and-neck carcinomas are caused by high-risk types of the human papillomavirus (hrHPV). During hrHPV-induced malignant transformation keratinocytes become able to grow anchorage independently, a tumorigenic trait at least partly associated with inactivation of tumor suppressor genes. We used hrHPV-containing keratinocytes to investigate the role of DNA methylation-mediated silencing of microRNAs (miRNAs) in the acquisition of anchorage independence.Anchorage dependent (n=11) and independent passages (n=19) of 4 hrHPV-immortalized keratinocyte cell lines were treated with 2'-deoxy-5-azacytidine (DAC). Genome-wide miRNA expression profiles before and after treatment were compared to identify miRNAs silenced by methylation. Bisulfite sequencing and methylation-specific PCR showed increased methylation of hsa-mir-129-2/-137/-935/-3663/-3665 and -4281 in anchorage independent HPV-transformed keratinocytes and cervical cancer cell lines. Mature miRNAs derived from hsa-mir-129-2/-137/-3663 and -3665 showed functional relevance as they decreased anchorage independence in cervical cancer cell lines. Cervical (pre)cancerous lesions demonstrated increased methylation of hsa-mir-129-2/-935/-3663/-3665 and -4281, underlining the clinical relevance of our findings.In conclusion, methylation-mediated silencing of tumor suppressive miRNAs contributes to acquisition of an anchorage independent phenotype. This study further substantiates the importance of miRNAs during early stages of carcinogenesis and underlines their potential as both disease markers and therapeutic targets.

Indexed as

Cell LineCell Line, TumorCell Transformation, ViralDNA MethylationFemaleGene Expression Regulation, NeoplasticGene SilencingHumansKeratinocytesMicroRNAsPapillomaviridaePapillomavirus InfectionsUterine Cervical NeoplasmsMicroRNAsanoikiscervical cancerCIN lesionDNA methylation

Identifiers

PMID27270309
PMCPMC5190061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.